FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362604374> ?p ?o ?g. }

• W4362604374 endingPage "110151" @default.
• W4362604374 startingPage "110151" @default.
• W4362604374 abstract "Waning vaccine-induced immunity and emergence of new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants which may lead to immune escape, pose a major threat to the COVID-19 pandemic. Currently, enhanced efficacy of the neutralization antibodies (NAb) produced after the booster dose of vaccinations against the Omicron variant is the main focus of vaccine strategy research. In this study we have analyzed the potency of the NAbs and IgGs produced after the third vaccine dose in patients infected with Omicron variant and wild-type (WT) SARS-CoV-2.We enrolled 75 patients with Omicron variant breakthrough infections, and 87 patients with WT infections. We recorded the clinical characteristics and vaccination information of all patients and measured the NAb and anti-S1 (spike protein) + N (nucleocapsid protein) IgG-binding antibodies against SARS-CoV-2 in serum samples of Omicron variant-infected patients at admission, and patients with WT COVID-19 infection from the time of admission and discharge, and one-year to two-years follow-ups.Our results demonstrated higher NAb levels, fewer clinical symptoms, and faster viral shedding in Omicron variant infected patients vaccinated with the booster dose. Hybrid immunity (natural infection plus vaccination) induces higher NAb levels than vaccine-only immunity. NAb and IgG levels decreased significantly at one-year follow-up in WT convalescents with natural infection. The NAb and IgG levels in booster-vaccinated COVID-19 patients were higher than those in two-dose-vaccinated patients.Our results suggest that booster vaccinations are required to improve the level of protective NAbs. Moreover, our data provide important evidence for vaccination strategies based on existing vaccines." @default.
• W4362604374 created "2023-04-06" @default.
• W4362604374 creator A5003375535 @default.
• W4362604374 creator A5022321726 @default.
• W4362604374 creator A5026630931 @default.
• W4362604374 creator A5027835055 @default.
• W4362604374 creator A5032132385 @default.
• W4362604374 creator A5037677450 @default.
• W4362604374 creator A5050196319 @default.
• W4362604374 creator A5052033110 @default.
• W4362604374 creator A5065750950 @default.
• W4362604374 creator A5067215312 @default.
• W4362604374 creator A5067404460 @default.
• W4362604374 creator A5076498651 @default.
• W4362604374 creator A5079440717 @default.
• W4362604374 date "2023-06-01" @default.
• W4362604374 modified "2023-10-17" @default.
• W4362604374 title "Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents" @default.
• W4362604374 cites W3111255098 @default.
• W4362604374 cites W3142193311 @default.
• W4362604374 cites W3163785571 @default.
• W4362604374 cites W3185377111 @default.
• W4362604374 cites W3194955934 @default.
• W4362604374 cites W4200059599 @default.
• W4362604374 cites W4200230275 @default.
• W4362604374 cites W4210664421 @default.
• W4362604374 cites W4214902244 @default.
• W4362604374 cites W4220673385 @default.
• W4362604374 cites W4220807057 @default.
• W4362604374 cites W4221072241 @default.
• W4362604374 cites W4221116249 @default.
• W4362604374 cites W4223581113 @default.
• W4362604374 cites W4224232962 @default.
• W4362604374 cites W4224277542 @default.
• W4362604374 cites W4225982774 @default.
• W4362604374 cites W4226060569 @default.
• W4362604374 cites W4280578452 @default.
• W4362604374 cites W4302293777 @default.
• W4362604374 cites W4308370730 @default.
• W4362604374 doi "https://doi.org/10.1016/j.intimp.2023.110151" @default.
• W4362604374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37044040" @default.
• W4362604374 hasPublicationYear "2023" @default.
• W4362604374 type Work @default.
• W4362604374 citedByCount "0" @default.
• W4362604374 crossrefType "journal-article" @default.
• W4362604374 hasAuthorship W4362604374A5003375535 @default.
• W4362604374 hasAuthorship W4362604374A5022321726 @default.
• W4362604374 hasAuthorship W4362604374A5026630931 @default.
• W4362604374 hasAuthorship W4362604374A5027835055 @default.
• W4362604374 hasAuthorship W4362604374A5032132385 @default.
• W4362604374 hasAuthorship W4362604374A5037677450 @default.
• W4362604374 hasAuthorship W4362604374A5050196319 @default.
• W4362604374 hasAuthorship W4362604374A5052033110 @default.
• W4362604374 hasAuthorship W4362604374A5065750950 @default.
• W4362604374 hasAuthorship W4362604374A5067215312 @default.
• W4362604374 hasAuthorship W4362604374A5067404460 @default.
• W4362604374 hasAuthorship W4362604374A5076498651 @default.
• W4362604374 hasAuthorship W4362604374A5079440717 @default.
• W4362604374 hasBestOaLocation W43626043741 @default.
• W4362604374 hasConcept C121332964 @default.
• W4362604374 hasConcept C12590561 @default.
• W4362604374 hasConcept C126322002 @default.
• W4362604374 hasConcept C1276947 @default.
• W4362604374 hasConcept C14086860 @default.
• W4362604374 hasConcept C159047783 @default.
• W4362604374 hasConcept C159654299 @default.
• W4362604374 hasConcept C202751555 @default.
• W4362604374 hasConcept C203014093 @default.
• W4362604374 hasConcept C203165030 @default.
• W4362604374 hasConcept C22070199 @default.
• W4362604374 hasConcept C2779134260 @default.
• W4362604374 hasConcept C2779261636 @default.
• W4362604374 hasConcept C2779341262 @default.
• W4362604374 hasConcept C2780441014 @default.
• W4362604374 hasConcept C3007834351 @default.
• W4362604374 hasConcept C3008058167 @default.
• W4362604374 hasConcept C32611913 @default.
• W4362604374 hasConcept C524204448 @default.
• W4362604374 hasConcept C55493867 @default.
• W4362604374 hasConcept C57992300 @default.
• W4362604374 hasConcept C71924100 @default.
• W4362604374 hasConcept C86803240 @default.
• W4362604374 hasConcept C8891405 @default.
• W4362604374 hasConceptScore W4362604374C121332964 @default.
• W4362604374 hasConceptScore W4362604374C12590561 @default.
• W4362604374 hasConceptScore W4362604374C126322002 @default.
• W4362604374 hasConceptScore W4362604374C1276947 @default.
• W4362604374 hasConceptScore W4362604374C14086860 @default.
• W4362604374 hasConceptScore W4362604374C159047783 @default.
• W4362604374 hasConceptScore W4362604374C159654299 @default.
• W4362604374 hasConceptScore W4362604374C202751555 @default.
• W4362604374 hasConceptScore W4362604374C203014093 @default.
• W4362604374 hasConceptScore W4362604374C203165030 @default.
• W4362604374 hasConceptScore W4362604374C22070199 @default.
• W4362604374 hasConceptScore W4362604374C2779134260 @default.
• W4362604374 hasConceptScore W4362604374C2779261636 @default.
• W4362604374 hasConceptScore W4362604374C2779341262 @default.
• W4362604374 hasConceptScore W4362604374C2780441014 @default.

• next